首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Attenuation of human nasal airway responses to bradykinin and histamine by inhibitors of nitric oxide synthase.
【2h】

Attenuation of human nasal airway responses to bradykinin and histamine by inhibitors of nitric oxide synthase.

机译:一氧化氮合酶抑制剂可减轻人鼻气道对缓激肽和组胺的反应。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. The effects of inhibitors of nitric oxide synthase and local anaesthetics were studied on changes in human nasal airway patency and albumin extravasation in response to bradykinin and histamine, in vivo. 2. Compared with the action of the vasoconstrictor, ephedrine, 2.5 mumol, NG-nitro-L-arginine methyl ester (L-NAME), 1 mumol alone, did not change the resting value of the minimal cross-sectional area (A min) of the human nasal airway. L-NAME, 0.1 to 10 mumol, produced a dose-related inhibition of the reduction in A min caused by bradykinin, 300 micrograms. NG-monomethyl-L-arginine (L-NMMA), 1 mumol, similarly reduced the effect of bradykinin, 300 micrograms, on A min, but NG-nitro-D-arginine methyl ester (D-NAME), had no effect. L-NAME, 0.1 to 10 mumol, or L-NMMA, 10 mumol, failed to inhibit the effect of histamine, 300 micrograms on A min. 3. The inhibition by L-NAME, 1 mumol of the action of bradykinin, 300 micrograms on A min was maximal between 15 and 30 min after pretreatment with L-NAME. 4. L-NAME, 1 and 10 mumol, inhibited the extravasation of albumin into the nasal cavity induced by bradykinin, 300 micrograms, and also by histamine, 300 micrograms. D-NAME, 1 and 10 mumol had no effect on the extravasation of albumin in response to bradykinin or histamine. 5. L-Arginine, 30 mumol, reversed the effect of L-NAME, 1 mumol, on the bradykinin- and histamine-induced albumin extravasation into the nasal airway. 6. Local anaesthesia of the nasal airway with lignocaine, 10 mg, or benzocaine, 10 mg, failed to inhibit the reduction in A min or the albumin extravasation induced by either bradykinin, 300 micrograms, and histamine, 300 micrograms. 7. We conclude that the extravasation of plasma albumin caused by bradykinin and by histamine involves the generation of nitric oxide. The nasal blockage induced by bradykinin involves nitric oxide generation but the nasal blockage induced by histamine does not.
机译:1.在体内研究了一氧化氮合酶抑制剂和局部麻醉剂对响应缓激肽和组胺的人鼻气道通畅性和白蛋白渗出的影响。 2.与血管收缩药的作用相比,单独使用1 mol的麻黄碱2.5 mol,NG-硝基-L-精氨酸甲酯(L-NAME)不会改变最小横截面积的静置值(A min )的人鼻气道。 L-NAME(0.1至10摩尔)对300微克缓激肽引起的A min降低产生剂量相关的抑制作用。 NG-单甲基-L-精氨酸(L-NMMA)(1摩尔)类似地降低了300微克缓激肽对A min的作用,但NG-硝基-D-精氨酸甲酯(D-NAME)没有作用。 0.1至10摩尔的L-NAME或10摩尔的L-NMMA未能抑制300微克组胺对A min的作用。 3.用L-NAME预处理后,在15分钟至30分钟内,对A min的抑制作用最大,即1μmol缓激肽300 mg对A min的抑制作用最大。 4. L-NAME(1和10摩尔),抑制了300微克缓激肽和300微克组胺引起的白蛋白渗入鼻腔。 D-NAME,1和10 mumol对响应缓激肽或组胺的白蛋白渗出没有影响。 5. 30μmol的L-精氨酸逆转了1μmol的L-NAME对缓激肽和组胺诱导的白蛋白渗入鼻道的作用。 6.用10 mg的利诺卡因或10 mg的苯佐卡因对鼻道进行局部麻醉不能抑制A min的降低或300毫克缓激肽和300毫克组胺引起的白蛋白渗出。 7.我们得出结论,缓激肽和组胺引起的血浆白蛋白外渗涉及一氧化氮的产生。缓激肽引起的鼻腔阻塞涉及一氧化氮的产生,而组胺引起的鼻腔阻塞则没有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号